| Code | 65561 | ||||||||||
| MA number | EU/1/07/401/007 | ||||||||||
| Product Form: | cps dur 42x60 mg (fľ.HDPE) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | GlaxoSmithKline Dungarvan Ltd., Ireland | ||||||||||
| Therapeutic Class: | 08 - ANOREXICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | bottle HDPE | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10c informed consent application |
| MA issued: | 23.07.2007 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC Alli 12 2009.pdf
|
| Safety feature | No |
| Data update: | 05.11.2018 |
